THU0144 Performance of the ers-ra cardiovascular risk prediction tool: external validation in a large swedish cohort with ra

L. Ljung, P. Ueda, K.P. Liao, J.D. Greenberg, C.J. Etzel, D.H. Solomon, J. Askling
2018 THURSDAY, 14 JUNE 2018   unpublished
Conclusions: Patients with RA and HF have an unfavourable prognosis. One third of them were hospitalised for HF or died during follow-up. In addition to patient characteristics, smoking, insufficiently controlled inflammation and treatment with glucocorticoids significantly increased the risk of hospitalisation or death.
doi:10.1136/annrheumdis-2018-eular.2712 fatcat:vdk7p2ulyrhovgb3znwswsamvu